Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.34p
   
  • Change Today:
    -0.012p
  • 52 Week High: 0.75
  • 52 Week Low: 0.23
  • Currency: UK Pounds
  • Shares Issued: 742.80m
  • Volume: 350,307
  • Market Cap: £2.51m
  • RiskGrade: 435
  • Beta: 0.15

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Gerald Desler 128,668 £435

Major Shareholders

Notifier** Holding Value*
Mark Eccleston 22,746,187 £76,882
Adam Hargreaves 7,749,163 £26,192
SANDERSON CAPITAL PARTNERS LTD 5,000,000 £16,900
Monecor (London) Limited 3,520,629 £11,900
Spreadex Ltd 2,222,840 £7,513
Paul Richards 722,533 £2,442
Cairn Financial Advisers LLP 332,308 £1,123
Jarvis Investment Management Ltd 129,436 £438
Peter James Crowson 3,383 £11

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.34p
Change Today -0.012p
% Change -3.43 %
52 Week High 0.75
52 Week Low 0.23
Volume 350,307
Shares Issued 742.80m
Market Cap £2.51m
Beta 0.15
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.52% above the market average41.52% above the market average41.52% above the market average41.52% above the market average41.52% above the market average
46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average
Price Trend
87.83% below the market average87.83% below the market average87.83% below the market average87.83% below the market average87.83% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average
Income Not Available
Growth
26.62% above the market average26.62% above the market average26.62% above the market average26.62% above the market average26.62% above the market average
31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average

Valirx Dividends

No dividends found

Trades for 30-Jan-2026

Time Volume / Share Price
08:03 39,539 @ 0.33p
08:00 310,768 @ 0.34p

Valirx Key Personnel

CFO Gerald Desler

Top of Page